Hypoparathyroidism Support Program
Published under two names: the Hypoparathyroidism Support Program, using the correct medical term, and the Hypopara Support Program, using the shorthand patients themselves use. Both names refer to this same program. Free, Australia‑wide support for people living with hypoparathyroidism, their families and their carers.
Four Things, All Free
The Hypoparathyroidism Support Program, also published as the Hypopara Support Program, is administered by CaSR Patient Support, an ACNC‑registered Australian health promotion charity. There is no fee, no membership cost and no requirement to have a confirmed genetic diagnosis to take part.
Peer Support
A national community of Australian patients, carers and families who live with the same condition. When a condition is this rare, many people go years without meeting anyone else who has it. The program exists to close that gap.
National Patient Registry
A consent‑first registry that helps quantify how many Australians live with these conditions. Numbers matter: when treatment access decisions are made, an uncounted patient population is an ignored one.
Information You Can Trust
Plain‑language explanations of the condition, its day‑to‑day management and the emerging treatment landscape, reviewed by our Medical Advisory Board so what you read between appointments is accurate.
Treatment Access Advocacy
New treatments for calcium‑sensing receptor disorders are in late‑stage trials. The program carries the patient voice into Australian access decisions so people here are not left waiting years behind other countries.
Any Australian Affected by Hypoparathyroidism
Hypoparathyroidism means the body does not make enough parathyroid hormone, which makes blood calcium hard to keep stable. The program is open to people affected by it however they came to it.
Genetic and Non‑Surgical Hypoparathyroidism
Including autosomal dominant hypocalcaemia type 1 (ADH1), caused by inherited changes in the calcium‑sensing receptor gene. This is CaSR Patient Support’s founding focus and the area where Australia has had no dedicated patient organisation. ADH1 families can also use our ADH1 Support Program.
Post‑Surgical Hypoparathyroidism
Hypoparathyroidism that follows thyroid or neck surgery. The cause differs but much of the daily reality, calcium management, symptom load and the search for informed clinicians, is shared. You are welcome here.
Not sure whether it applies to you?
You do not need a genetic test result, a specialist referral or a formal diagnosis code to join. If low calcium is part of your life, or your child’s, start with our plain‑language explanation of the calcium‑sensing receptor and patient resources.
Joining Takes About Two Minutes
One short, consent‑first form. You choose what you share, and you can share nothing about your health at all and still join.
Patients, Families and Carers
Join the national community and the patient registry in the same step. Free, and you can withdraw at any time.
Clinicians
There is no formal referral process and no cost to your patient. Point them here, or get in touch about the Medical Advisory Board.
Share Your Experience
Patient stories are what move decision‑makers. Contribute yours to the program on your own terms, named or anonymous.
About This Program
Program names: Hypoparathyroidism Support Program (formal name, using the correct medical term) and Hypopara Support Program (short name, using the patient community’s own shorthand). Both are published names of this one program; neither is a separate program.
Administered by: CaSR Patient Support, ABN 11 855 673 895, an ACNC‑registered Australian health promotion charity, endorsed as a deductible gift recipient.
Scope: hypoparathyroidism in all its forms, with a founding focus on non‑surgical genetic hypoparathyroidism and autosomal dominant hypocalcaemia type 1 (ADH1).
Delivered: Australia‑wide, online, free of charge.
Clinical governance: patient information and advocacy positions are reviewed by CaSR’s Medical Advisory Board, headed by Prof Roderick Clifton‑Bligh.
Program names adopted: Hypopara Support Program on 10 August 2026; Hypoparathyroidism Support Program added as the formal name on 11 August 2026. CaSR Patient Support has been an ACNC‑registered health promotion charity for these conditions since 18 January 2022; this page names the support services it provides.
Page last reviewed: 11 August 2026.
Contact: enquiries@casr.org.au or 1800 431 231.